“2013 Gap Fill Payment Amounts to the Clinical Lab Fee Schedule.” Letter to CMS Director Marilyn Tavenner, July 8, 2013.
“Concerns about the Palmetto Molecular Diagnostics (MolDx) Services Program and Medicare Coverage as well as Their Impact on Gap-Fill Pricing for Molecular Pathology Procedures.” Letter to CMS Director Marilyn Tavenner, October 30, 2013.
AMP Position Statements and Letters–2013.
Concern over Protecting Access to Medicare Act of 2014, Section 216, “Improving Medicare Policies for Clinical Diagnostic Laboratories.” Letter to Senate Majority Leader Harry Reid, March 27, 2014.